Results 281 to 290 of about 96,185 (308)

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial

Lancet, The, 2023
Anne-Sophie Debrie, Stephanie Noviello, Qiushui He   +2 more
exaly  

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

Cell Host and Microbe, 2021
Maryline Bourgine, Pierre Authié, Jodie Lopez   +2 more
exaly  

INTRANASAL ADMINISTRATION OF LUTEINISING-HORMONE RELEASING FACTOR

The Lancet, 1974
G, Gennser, P, Liedholm
openaire   +2 more sources

Clinical Practice Guideline: Intranasal Medication Administration

Journal of Emergency Nursing, 2018
openaire   +2 more sources

Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial

Lancet, The, 2006
Elizabeth M Molyneux
exaly  

Paradoxical reaction after intranasal midazolam administration

Medicina Clínica (English Edition), 2017
Ariadna Ayerza Casas, Verónica Ayerza Casas, Pablo Crespo Escudero   +2 more
openaire   +1 more source

Management of suspected acute viral upper respiratory tract infection in children with intranasal sodium cromoglicate: a randomised controlled trial

Lancet, The, 2002
Hayley C Prout, Kerenza Hood
exaly  

INTRANASAL ADMINISTRATION OF LH‐RELEASING HORMONE

Acta Obstetricia et Gynecologica Scandinavica, 1975
O. Meirik, T. Bergh, S. J. Nillius, L. Wide   +3 more
openaire   +1 more source

Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland

New England Journal of Medicine, 2004
Margot Mütsch, Matthias Bopp
exaly  

DMP-755: intranasal administration feasible?

Inpharma Weekly, 1998
openaire   +1 more source